Furosemide

From WikEM
Jump to: navigation, search

General

  • Type: Diuretic
  • Dosage Forms:20, 40, 80
  • Common Trade Names: Lasix
  • Approximately 50% bioavailability, so converting from oral to IV dose doubles oral dose[1]
  • Furosemide absorption may be reduced in decompensated CHF[2]

Adult Dosing

40 mg furosemide = 20 mg torsemide = 1 mg bumetanide = 50 mg ethacrynic acid

  • Fluid overload: Typically 40 mg IV or normal PO dosage IV
  • hypertension: 10-40 mg PO QDAY-BID, max 600 mg/day
  • Hypercalcemia: 120 mg/day PO divided QDAY - TID
  • Continuous infusion may increase diuresis effect and minimize post-diuretic sodium retention and "diuretic braking"[3]
    • Start 0.1 mg/kg/hr, increase hourly to max of 0.75 mg/kg/hr[4]
    • Target > 1 mL/kg/hr
    • Monitor for ototoxicity

Pediatric Dosing

Special Populations

  • Pregnancy Rating:C
  • Lactation: safety unknown
  • Renal Dosing
    • Adult: no adjustment, contraindicated in anuria
    • Pediatric: no adjustment, contraindicated in anuria
  • Hepatic Dosing
    • Adult: not defined
    • Pediatric: not defined

Contraindications

  • Allergy to class/drug
  • anuria
  • electrolyte imbalances

Adverse Reactions

Serious

  • hypokalemia
  • metabolic alkalosis
  • hypovolemia
  • ototoxicity
  • hemolytic anemia
  • vasculitis
  • steven-johnson syndrome
  • pancreatitis
  • eosinophilia

Common

  • urinary frequency
  • dizziness
  • nausea/vomiting
  • weakness
  • muscle cramping
  • hypokalemia
  • hypomagnesemia
  • blurred vision
  • diarrhea
  • hyperglycemia
  • hyperuricemia
  • tinnitus

Pharmacology

  • Half-life: 30-60 min
  • Metabolism: liver minimally
  • Excretion: urine
  • Mechanism of Action: inhibits loop of henle and proximal and distal convoluted tubule sodium and chloride resorption

See Also

References

  1. ↑ Asare K. Management of Loop Diuretic Resistance in the Intensive Care Unit. Am J Health Syst Pharm. 2009;66(18):1635-1640.
  2. ↑ Vasko MR, Brown-Cartwright D, Knochel JP et al. Furosemide absorption is altered in decompensated congestive heart failure. Ann Intern Med. 1985; 102: 314–8.
  3. ↑ Pivac N, Rumboldt Z, Sardelic S et al. Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure. Int J Clin Pharmacol Res. 1998; 18:121–8.
  4. ↑ Schuller D, Lynch JP, Fine D. Protocol-guided diuretic management: comparison of furosemide by continuous infusion and intermittent bolus. Crit Care Med. 1997; 25:1969–75.